Bibliometric analysis of randomized controlled trials of colorectal cancer over the last decade

Table 3 Top 10 cited colorectal cancer randomized controlled trial-related literature in the domestic and international publications in 2008-2018

Ref.	Title	Journal	Cited	Year
Nordlinger et al[3]	Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): A randomized controlled trial	Lancet	1104	2008
Atkin et al[4]	Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: A multicentre randomised controlled trial	Lancet	961	2010
Grothey et al[5]	Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): An international, multicentre, randomised, placebo-controlled, phase 3 trial	Lancet	935	2013
Tol et al[6]	Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer	New England Journal of Medicine	904	2009
Baxter et al[7]	Association of colonoscopy and death from colorectal cancer	Annals of Internal Medicine	835	2009
Hecht et al[8]	A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer	Journal of Clinical Oncology	596	2009
Maughan et al[9]	Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: Results of the randomised phase 3 MRC COIN trial	Lancet	574	2011
Peeters et al[10]	Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer	Journal of Clinical Oncology	549	2010
Folprecht et al[11]	Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: The CELIM randomised phase 2 trial	Lancet Oncology	523	2010
Verwaal et al[12]	8-year follow-up of randomized trial: Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer	Annals of Surgical Oncology	448	2008